Search Results
Jan 20, 2026, 07:00 ET Clinical Trial Demonstrates Accurate Non-Invasive Detection of In Vivo Biologic Activity in Melanomas by the Orlucent® Skin Fluorescent Imaging System
cancers early compared to current clinical practice."This is a major step forward for non-invasive skin cancer diagnostics," said Douglas Grossman, MD, of Utah's Huntsman Cancer Institute and the study's lead author. "Skin Fluorescent Imaging lets doctors see melanoma molecular activity in the skin,
More news about: Orlucent, Inc.
Jan 20, 2026, 06:00 ET Ouma Health and Valley Healthcare Restore Local Maternity Care Through Innovative Telemidwifery and TeleMFM Partnership
U.S., maternity units are closing not because communities don't need them, but because staffing them has become unsustainable," said Sina Haeri, MD, MHSA, CEO of Ouma Health. "This partnership with Valley Health demonstrates that maternity services don't have to disappear. By expanding telehealth
More news about: Ouma Health
Jan 20, 2026, 05:25 ET Genesis Innovation Group Announces New Subsidiary Capitan Orthopedics, Inc.
option that positively impacts patient care," said Chance Leonard, CEO of Genesis Innovation Group and Capitan Orthopedics, Inc.R. Sean Churchill, MD, MBA, lead surgeon designer said, "It's exciting to work with Capitan Orthopedics as the company has taken on the challenge of addressing one of the most
More news about: Genesis Innovation Group
Jan 20, 2026, 01:51 ET EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer's therapy into clinical Phase 2
the Phase 2 trials are positive, it would be a significant milestone in symptomatic treatment options for patients with AD."Philip Scheltens, MD, PhD, Partner at EQT Life Sciences, said: "This investment illustrates the potential of Exciva to bring exciting innovation to a therapeutic area where
More news about: EQT
Jan 20, 2026, 01:48 ET EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer's therapy into clinical Phase 2
the Phase 2 trials are positive, it would be a significant milestone in symptomatic treatment options for patients with AD."Philip Scheltens, MD, PhD, Partner at EQT Life Sciences, said: "This investment illustrates the potential of Exciva to bring exciting innovation to a therapeutic area where
More news about: EQT
Jan 19, 2026, 14:48 ET The Inner Circle acknowledges, Andrij O Baran, MD, FACC as a Pinnacle Lifetime Member
SARATOGA SPRINGS, N.Y., Jan. 19, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Andrij O Baran, MD, FACC is acknowledged as a Pinnacle Lifetime Member for his contributions as a Distinguished Cardiologist and Community Leader with Over Four Decades
More news about: The Inner Circle
Jan 19, 2026, 11:00 ET Beyond Resilience: New Research to Validate 'Internal Technology' as the Cure for Executive Burnout
Adversity-Driven Leadership (ADL)™ Launches Strategic Cohort to Engineer Adversity into Competitive Advantage.LEONARDTOWN, Md., Jan. 19, 2026 /PRNewswire/ -- The era of "resilience" is over. Inspirational Endeavors, LLC, a cognitive engineering
More news about: INSPIRATIONAL ENDEAVORS,LLC
Jan 19, 2026, 09:02 ET GSE Solutions Acquires Iddeal, Strengthening Nuclear Engineering Program Capabilities
COLUMBIA, Md., Jan. 19, 2026 /PRNewswire/ -- GSE Solutions, a leader in advanced engineering services, technology and expertise for nuclear and energy generation fleets worldwide, today announced the acquisition of Iddeal Concepts
More news about: GSE SOLUTIONS
Jan 19, 2026, 05:25 ET Shriram AMC Expands Fixed Income Suite with Launch of Shriram Money Market Fund
the evolving liquidity, duration, and risk management needs of institutional treasuries, corporates, HNIs, and retirees.Mr. Kartik L Jain, MD & CEO, Shriram Asset Management Company Limited, said, "As liquidity management becomes a core component of portfolio construction across
More news about: Shriram Asset Management Company Limited
Jan 18, 2026, 19:30 ET AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
ROCKVILLE, Md. and SHANGHAI, Jan. 18, 2026 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based
More news about: AbelZeta Pharma, Inc.
Jan 16, 2026, 15:45 ET Linganore Winecellars Toasts to 50 Years of Maryland Winemaking in 2026
Maryland Vineyard Honors Half a Century with Special Events and PromotionsMOUNT AIRY, Md., Jan. 16, 2026 /PRNewswire/ -- Half a century ago, a vision took root in the rolling hills of Frederick County.
More news about: Linganore Winecellars
Jan 16, 2026, 13:48 ET Dr. Sajad Zalzala Announces Scholarship for Healthcare Professionals: Advancing Root-Cause Solutions in Modern Medicine and Preventive Health Innovation
Dr. Sajad Zalzala, MD, invites currently enrolled undergraduate students nationwide to apply for funding that recognizes academic excellence and innovative thinking in healthcare.Scholarship
More news about: Dr. Sajad Zalzala Scholarship
Jan 16, 2026, 11:31 ET Mistral and UVision Team Announces HERO-90 Selection for U.S. Army's LASSO Program
BETHESDA, Md., Jan. 16, 2026 /PRNewswire/ -- Mistral Inc. and its teammate UVision Inc. today announced that the HERO-90 loitering munition has been selected by Program Executive Office (PEO) Soldier to participate in the U.S.
More news about: Mistral Inc.
Jan 16, 2026, 11:00 ET Equinox Integrates Oura Ring Data Into EQX ARC, New Women's Health & Performance Program
integration reflects a shared commitment to advancing women's health through data-informed, personalized training programs," said Dr. Chris Curry, MD, PhD, Clinical Director of Women's Health at ŌURA. "Oura's insights help women understand how their bodies respond to training, stress, last nights'
More news about: Equinox Group
Jan 16, 2026, 10:00 ET From Awareness to Action: Linus Health Drives the Next Era of Early Brain Health Detection
media interviews focused on the future of brain health and AI-enabled care, including:Chief Operating Officer John Showalter, MD,
More news about: Linus Health
Jan 16, 2026, 08:57 ET "Citadel Aviation Launches 2026 with 13 VIP Aircraft Projects, Redefining Advanced Technology and Connectivity Upgrades"
Elevate Your Aviation Experience?Experience unparalleled support and cutting-edge innovation with Citadel Aviation.Media Contact:MD [email protected]
More news about: Citadel Aviation
Jan 16, 2026, 08:33 ET TELUS completes redemption of 3.75% Notes, Series CV due March 10, 2026
be read together with the risk factors and assumptions set out in our 2024 annual management's discussion and analysis ("MD&A"), and updated in our third quarter 2025 MD&A, and in other TELUS public disclosure documents and filings with securities commissions in Canada (on SEDAR+ at
More news about: TELUS Corporation
Jan 16, 2026, 08:33 ET TELUS completes redemption of 3.75% Notes, Series CV due March 10, 2026
be read together with the risk factors and assumptions set out in our 2024 annual management's discussion and analysis ("MD&A"), and updated in our third quarter 2025 MD&A, and in other TELUS public disclosure documents and filings with securities commissions in Canada (on SEDAR+ at
More news about: TELUS Corporation
Jan 16, 2026, 08:30 ET URBAN ONE, INC. ANNOUNCES REVERSE STOCK SPLIT
SILVER SPRING, Md., Jan. 16, 2026 /PRNewswire/ -- Urban One, Inc. (Nasdaq: UONE and UONEK) (the "Company"), today announced that its Board of Directors (the "Board") has approved a reverse stock split of all classes of its
More news about: Urban One, Inc.
Jan 16, 2026, 08:14 ET AllyGPO and BioCareSD Welcome Retina Associates of Cleveland, Highlighting the Market Need for New Transparent, Technology-Forward Options
conditions."Maintaining our independence is central to how RACI cares for patients, and we value partners who support this," said President of RACI David G. Miller, MD. "BioCareSD and AllyGPO, through consistent actions and collaboration, have demonstrated their genuine commitment to preserving community retina practice
More news about: AllyGPO and BioCareSD
Jan 16, 2026, 08:00 ET Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
escalation. The efficacy is clear at 8 mg/kg, with robust ORRs, including in subgroups defined by low PD-L1 and/or CLDN18.2 expression," said Phillip Dennis, MD, PhD, Chief Medical Officer of NovaBridge. "We remain enthusiastic about the 12 mg/kg dose because exposure analysis shows higher exposure is consistently
More news about: Equity Insider
Jan 16, 2026, 07:58 ET 5th Seed to Spoon Summit: Master Your Food, Health & Future in OH!
MAHA Action, and Julian Douwes, MD, from
More news about: Superb Sealing Solutions LLC
Jan 16, 2026, 06:49 ET Sobi Receives European Commission Approval for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Europe, two severe and rare kidney diseases with limited treatment options and a high risk of progression to kidney failure," said Lydia Abad-Franch, MD, Head of R&D and Medical Affairs, and Chief Medical Officer at Sobi. "This approval is underpinned by robust clinical evidence from the VALIANT trial,
More news about: Swedish Orphan Biovitrum AB
Jan 16, 2026, 06:02 ET Doceree Sets the Global Standard for Healthcare Marketing, Building the World's Largest Network of Specialist Medical Publishers
advertising into meaningful medical dialogue."Healthcare marketing has outgrown generic programmatic models," said Harshit Jain, MD, Founder & Global CEO, Doceree. "What we've built with this publisher network is not just scale, but infrastructure—designed specifically
More news about: Doceree
Jan 16, 2026, 04:32 ET Astec LifeSciences to Showcase Manufacturing and ESG Leadership at PMFAI's ICSCE Dubai
maintaining stringent safety, quality and sustainability standards.Burjis Godrej, Executive Director, Godrej Agrovet Limited and MD, Astec LifeSciences Limited, said, "Our manufacturing platform is designed for flexibility, safety, and export readiness on a large scale. With multipurpose
More news about: Astec LifeSciences